Human growth hormone (hGH) therapy is one of the most talked about "youth" therapies available today. Allure magazine, in its "Anti-aging Special" issue, highlighted growth hormone as its 2013 call-out. Shape magazine began a recent growth hormone article with the provocative lead in: "When you see a 50-year-old actress who can pass for 35, you can bet that good genes aren't the only things responsible for her youthful glow." And now the United States Patent Office has issued a U.S. Patent for the SeroVital® formula, an oral growth hormone booster that's been clinically validated to raise mean, serum (blood) hGH levels by 682%.
United States Patent Number 8,551,542 protects the SeroVital formula as a method and composition for increasing growth hormone. The background of the patent says, "The primary biological function of human growth hormone (hGH) includes stimulating growth, cell repair and regeneration. Once the primary growth period of adolescence concludes, the primary function of hGH in adulthood becomes that of cell regeneration and repair, helping to regenerate skin, bones, heart, lungs, liver and kidneys to their optimal, youthful cell levels… Some embodiments [of the SeroVital formula] include a method for increasing growth hormone (e.g., hGH) in a subject (e.g., a human subject) that comprises orally administering a nutritional supplement to a subject to improve one or more objective health metrics, including for example and without limitation: increasing lean body mass; reducing obesity, adipose tissue mass, and anxiety; supporting weight loss; decreasing appetite and atrophic processes in skeletal muscle, liver, kidney, spleen, skin, and bone; and improving at least one of energy, endurance, sleep, metabolism, heart rate, blood pressure, cardiovascular health, sympathetic nervous activity, thyroid response, glucose utilization, mental/cognitive function, reaction time, bone density, hair health and appearance, nail health and appearance, skin health and appearance, and libido."
"We are extremely excited about being granted this patent," says Chantelle Daines, spokesperson for SanMedica International™, SeroVital's distributor. "There are hundreds of products on the market that claim to increase growth hormone levels without injections. We're very proud to receive the distinction of having a United States Patent that protects our SeroVital formula from imitators."
SeroVital makes it possible for people to increase their human growth hormone levels through an entirely different approach than hGH injections offer. "Rather than introducing synthetic hGH into the body via injections, SeroVital increases the body's own, endogenous levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH," says Dr. Amy Heaton, PhD, Director of Scientific Affairs for SanMedica International.
In addition to allowing consumers to increase their hGH levels naturally, SeroVital offers another benefit. As the patent information points out, "Until recently, hGH was available only in expensive injectable forms, and benefits from the restoration of hGH levels available only to those with the ability to pay." But with SeroVital, consumers can increase their hGH levels for a fraction of the cost of synthetic injections… about $100 a month rather than the $1000-$1500 per month they would pay for injections.
